InsiderDB

Lobbying disclosures · Lobbying report

MCK: third_quarter 2026 lobbying report

ECAPS and Main Street Pharmacy Act; AI for clinical care; Protecting Patient Access to Cancer and Complex Therapies Act (Murphy)

Follow MCK
Became public
Oct 20, 2026, 10:52 AM EDT
Event / period date
Not stated
Collected
Nov 11, 2026, 1:39 PM EST

Why this is connected

Legal-name match: MCKESSON CORPORATION is MCKESSON CORP (https://www.sec.gov/Archives/edgar/data/927653/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported lobbying amounts

Income: $50,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/42581c1b-030d-4f02-9e08-0c63d4a5294b/","filing_uuid":"42581c1b-030d-4f02-9e08-0c63d4a5294b","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/42581c1b-030d-4f02-9e08-0c63d4a5294b/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"E. Ashley Hoy","dt_posted":"2026-10-20T10:52:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"975 F Street NW","registrant_address_2":"Suite 400 B","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":308775,"url":"https://lda.gov/api/v1/registrants/308775/","house_registrant_id":38429,"name":"MONUMENT ADVOCACY","description":"Government affairs and strategic consulting services","address_1":"975 F St NW","address_2":"Suite 400B","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"E. ASHLEY HOY","contact_telephone":"+1 202-719-9999","dt_updated":"2026-07-27T17:18:39.228569-04:00"},"client":{"id":71237,"url":"https://lda.gov/api/v1/clients/71237/","client_id":71237,"name":"MCKESSON CORPORATION","general_description":"Provider of medicines, pharmaceutical supplies and health IT products & services.","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ECAPS and Main Street Pharmacy Act; AI for clinical care; Protecting Patient Access to Cancer and Complex Therapies Act (Murphy)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153017,"prefix":null,"prefix_display":null,"first_name":"JOEL","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153019,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"STEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in MCK

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.